Literature DB >> 26730795

Can sexual outcomes be enhanced after cancer using online technology?

Addie C Wootten1, Brindha Pillay, Jo-Anne M Abbott.   

Abstract

PURPOSE OF REVIEW: The impact that cancer and its treatments can have on sexual functioning, sexual desire, and sexual arousal can be profound and many patients report significant unmet needs in relation to managing sexual difficulties. We reviewed the literature to understand the application of Internet-based technology in the delivery of psychosexual interventions, information provision, and support. RECENT
FINDINGS: Ten studies were identified that utilized Internet-based technology to deliver information, support, or psychosexual interventions designed to improve sexual outcomes, sexual distress, and quality of life of cancer survivors. The intensity of intervention, approach, and complexity differed substantially across platforms.
SUMMARY: The review identified a range of intervention types designed to enhance sexual outcomes following the challenges that many individuals face after cancer diagnosis and treatment. It is evident that the use of online technology in improving sexual outcomes in cancer care is still in its infancy; however, there is emerging evidence to support the delivery of psychosexual care using the online environment. Further research, using larger, more well controlled methodologies, is required to confirm that sexual outcomes can be improved through the use of online interventions.

Entities:  

Mesh:

Year:  2016        PMID: 26730795     DOI: 10.1097/SPC.0000000000000189

Source DB:  PubMed          Journal:  Curr Opin Support Palliat Care        ISSN: 1751-4258            Impact factor:   2.302


  1 in total

1.  Addressing sexual concerns of female breast cancer survivors and partners: a qualitative study of survivors, partners, and oncology providers about Internet intervention preferences.

Authors:  Kelly M Shaffer; Erin Kennedy; Jillian V Glazer; Anita H Clayton; Wendy Cohn; Trish A Millard; Lee M Ritterband; Shayna Showalter
Journal:  Support Care Cancer       Date:  2021-06-02       Impact factor: 3.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.